Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ORGO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Arthur S. Leibowitz Director | ORGO Organogenesis Holdings Inc. | Buy | 5,000 | $2.68 | $13.4K Buy | Form 4 ↗ |
| Mar 9, 2026 | Michael Joseph Driscoll Director | ORGO Organogenesis Holdings Inc. | Buy | 10,000 | $2.67 | $26.7K Buy | Form 4 ↗ |
| Dec 16, 2025 | Glenn H. Nussdorf Director | ORGO Organogenesis Holdings Inc. | Sale | 200,000 | $5.14 | $1.0M Sale | Form 4 ↗ |
| Nov 26, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Sale | 187,957 | $5.29 | $994.3K Sale | Form 4 ↗ |
| Nov 25, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Sale | 12,043 | $5.30 | $63.8K Sale | Form 4 ↗ |
| Nov 24, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Sale | 100,000 | $5.34 | $534.0K Sale | Form 4 ↗ |
| Jun 10, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Sale | 18,620 | $3.56 | $66.3K Sale | Form 4 ↗ |
| Jun 9, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Sale | 4,156 | $3.50 | $14.5K Sale | Form 4 ↗ |
| Jun 6, 2025 | Lori Freedman Chief Admin. and Legal Officer | ORGO Organogenesis Holdings Inc. | Buy | 9,022 | $2.99 | $27.0K Buy | Form 4 ↗ |
| Jun 5, 2025 | Lori Freedman Chief Admin. and Legal Officer | ORGO Organogenesis Holdings Inc. | Buy | 142,379 | $2.91 | $414.3K Buy | Form 4 ↗ |
| Jun 4, 2025 | Lori Freedman Chief Admin. and Legal Officer | ORGO Organogenesis Holdings Inc. | Buy | 100,863 | $2.82 | $284.4K Buy | Form 4 ↗ |
| May 15, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Buy | 107,494 | $2.99 | $321.4K Buy | Form 4 ↗ |
| May 14, 2025 | Glenn H. Nussdorf Director, 10% owner | ORGO Organogenesis Holdings Inc. | Buy | 251,001 | $3.09 | $775.6K Buy | Form 4 ↗ |
| Mar 4, 2025 | Michael Joseph Driscoll Director | ORGO Organogenesis Holdings Inc. | Sale | 25,000 | $5.10 | $127.5K Sale | Form 4 ↗ |
| Dec 16, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 5,585 | $3.49 | $19.5K Sale | Form 4 ↗ |
| Dec 13, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 55,615 | $3.36 | $186.9K Sale | Form 4 ↗ |
| Dec 12, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 43,359 | $3.55 | $153.9K Sale | Form 4 ↗ |
| Dec 11, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 157,448 | $3.64 | $573.1K Sale | Form 4 ↗ |
| Dec 10, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 58,525 | $3.64 | $213.0K Sale | Form 4 ↗ |
| Dec 9, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 41,052 | $3.52 | $144.5K Sale | Form 4 ↗ |
| Dec 6, 2024 | Gary S. Gillheeney President and CEO, Director | ORGO Organogenesis Holdings Inc. | Sale | 18,416 | $3.65 | $67.2K Sale | Form 4 ↗ |
21 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances